In December 2023, Pfizer reported a decrease in net sales, net profit, and EBITDA compared to the same period in 2022. Its EPS also decreased from Rs. 32.93 to Rs. 27.12. However, its shares have shown a positive return of 14.46% over the last six months and 16.94% over the last year. The company has not made any significant financial changes in terms of expenditure or reserves.